[Bone-marrow toxicity, lactic acidosis, and disseminated intravascular coagulation following phenformin medication].
D000368:Aged; D000740:Anemia / Q000209:etiology; D001145:Arrhythmias, Cardiac / Q000209:etiology; D001803:Blood Transfusion; D001855:Bone Marrow Diseases / Q000139:chemically induced*; D003072:Cognition Disorders / Q000209:etiology; D003920:Diabetes Mellitus / Q000188:drug therapy; D016883:Diabetic Ketoacidosis / Q000139:chemically induced* / Q000175:diagnosis; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced* / Q000175:diagnosis; D004912:Erythrocytes / Q000032:analysis; D005260:Female; D006406:Hematoma / Q000209:etiology; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007501:Iron / Q000097:blood; D007773:Lactates / Q000097:blood; D009461:Neurologic Manifestations; D010629:Phenformin / Q000009:adverse effects* / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000209:etiology; D013921:Thrombocytopenia / Q000209:etiology
D006454:Hemoglobins; D007773:Lactates; D010629:Phenformin; D007501:Iron
Knochenmarktoxizität, Laktatazidose und disseminierte intravasale Gerinnung nach Phenforminmedikation